Literature DB >> 1838201

Reversal of antidepressant action by dopamine antagonists in an animal model of depression.

D Sampson1, P Willner, R Muscat.   

Abstract

Rats subjected chronically (12 weeks) to a variety of mild, unpredictable stressors showed a reduced consumption of sucrose or a sucrose/saccharin mixture in two-bottle consumption tests (sweet solution versus water). The deficit was apparent within 2 weeks of stress; normal behaviour was restored by chronic (7 weeks) treatment with the tricyclic antidepressants desmethylimipramine (DMI) or amitriptyline (AMI). Acute administration of the dopamine D1 receptor antagonist SCH-23390 1 week after withdrawal, or the dopamine D2 receptor antagonist sulpiride 2 weeks after withdrawal, were without effect in vehicle-treated stressed animals, and in non-stressed animals. However, the DA antagonists selectively reversed the improvement of performance in DMI- or AMI-treated stressed animals. This suggests that an increase in functional activity at DA synapses is the mechanism of action of DMI and AMI in this model.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1838201     DOI: 10.1007/bf02245655

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

Review 1.  Animal models of depression: an overview.

Authors:  P Willner
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

2.  A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs.

Authors:  P Jenner; P N Elliott; A Clow; C Reavill; C D Marsden
Journal:  J Pharm Pharmacol       Date:  1978-01       Impact factor: 3.765

3.  Evidence that dopamine mechanisms in the nucleus accumbens are selectively involved in the effect of desipramine in the forced swimming test.

Authors:  L Cervo; R Samanin
Journal:  Neuropharmacology       Date:  1987-10       Impact factor: 5.250

4.  Evidence of dopamine involvement in the effect of repeated treatment with various antidepressants in the behavioural 'despair' test in rats.

Authors:  F Borsini; L Pulvirenti; R Samanin
Journal:  Eur J Pharmacol       Date:  1985-04-02       Impact factor: 4.432

5.  Repeated treatment with antidepressant drugs potentiates the locomotor response to (+)-amphetamine.

Authors:  J Maj; Z Rogóz; G Skuza; H Sowińska
Journal:  J Pharm Pharmacol       Date:  1984-02       Impact factor: 3.765

6.  Repeated treatment with amitriptyline reduces immobility in the behavioural 'despair' test in rats by activating dopaminergic and beta-adrenergic mechanisms.

Authors:  F Borsini; E Nowakowska; L Pulvirenti; R Samanin
Journal:  J Pharm Pharmacol       Date:  1985-02       Impact factor: 3.765

7.  The influence of oxaprotiline enantiomers given repeatedly on the behavioural effects of d-amphetamine and dopamine injected into the nucleus accumbens.

Authors:  J Maj; K Wedzony
Journal:  Eur J Pharmacol       Date:  1988-01-12       Impact factor: 4.432

8.  Cholinergic-dopaminergic interactions and the mechanisms of action of antidepressants.

Authors:  M T Martin-Iverson; J F Leclere; H C Fibiger
Journal:  Eur J Pharmacol       Date:  1983-10-28       Impact factor: 4.432

9.  Antagonism by dopamine, but not noradrenaline receptor blockers of the anti-immobility activity of desipramine after different treatment schedules in the rat.

Authors:  L Pulvirenti; R Samanin
Journal:  Pharmacol Res Commun       Date:  1986-01

10.  Repeated treatment with imipramine and amitriptyline reduced the immobility of rats in the swimming test by enhancing dopamine mechanisms in the nucleus accumbens.

Authors:  L Cervo; R Samanin
Journal:  J Pharm Pharmacol       Date:  1988-02       Impact factor: 3.765

View more
  23 in total

1.  Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline.

Authors:  R Muscat; M Papp; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Chronic fluoxetine selectively upregulates dopamine D₁-like receptors in the hippocampus.

Authors:  Katsunori Kobayashi; Eisuke Haneda; Makoto Higuchi; Tetsuya Suhara; Hidenori Suzuki
Journal:  Neuropsychopharmacology       Date:  2012-01-25       Impact factor: 7.853

3.  Interactions between endocannabinoids and stress-induced decreased sensitivity to natural reward.

Authors:  David J Rademacher; Cecilia J Hillard
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-12-28       Impact factor: 5.067

4.  An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress.

Authors:  M Papp; P Willner; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  Intra-nucleus accumbens shell injections of R(+)- and S(-)-baclofen bidirectionally alter binge-like ethanol, but not saccharin, intake in C57Bl/6J mice.

Authors:  Chelsea R Kasten; Stephen L Boehm
Journal:  Behav Brain Res       Date:  2014-07-12       Impact factor: 3.332

6.  Alterations in the levels of monoamines in discrete brain regions of clomipramine-induced animal model of endogenous depression.

Authors:  M Vijayakumar; B L Meti
Journal:  Neurochem Res       Date:  1999-03       Impact factor: 3.996

7.  Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine.

Authors:  S Monleon; P D'Aquila; A Parra; V M Simon; P F Brain; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

8.  Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole.

Authors:  P Willner; S Lappas; S Cheeta; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

9.  Stereospecific reversal of stress-induced anhedonia by mianserin and its (+)-enantiomer.

Authors:  S Cheeta; C Broekkamp; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

10.  Voltammetric evidence that subsensitivity to reward following chronic mild stress is associated with increased release of mesolimbic dopamine.

Authors:  J A Stamford; R Muscat; J J O'Connor; J Patel; S J Trout; W J Wieczorek; Z L Kruk; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.